NASDAQ: MRAIMarpai Inc Stock Ownership - Who owns Marpai?
Insider buying vs selling
Have Marpai Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Damien Lamendola | Chief Executive Officer | 2024-03-07 | 910,000 | $1.65 | $1.50MBuy |
| Yaron Eitan | Director | 2024-01-16 | 210,000 | $0.92 | $193.20kBuy |
| Damien Lamendola | Chief Executive Officer | 2024-01-16 | 1,100,000 | $0.92 | $1.01MBuy |
| Robert M. Pons | Director | 2024-01-16 | 12,100 | $0.92 | $11.13kBuy |
| Robert M. Pons | Director | 2023-12-14 | 12,100 | $1.81 | $21.90kBuy |
| Yaron Eitan | Director | 2023-12-14 | 50,000 | $1.97 | $98.50kBuy |
| Damien Lamendola | Chief Executive Officer | 2023-12-14 | 150,000 | $1.97 | $295.50kBuy |
| Damien Lamendola | Chief Executive Officer | 2023-11-21 | 200,000 | $1.19 | $238.60kBuy |
| Yaron Eitan | Director | 2023-11-17 | 100,000 | $1.23 | $123.00kBuy |
| Edmundo Gonzalez | Chief Executive Officer | 2023-09-11 | 42,000 | $0.77 | $32.34kBuy |
MRAI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MRAI insiders and whales buy or sell their stock.
MRAI Shareholders
What type of owners hold Marpai Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Damien Lamendola | 47.17% | 4,858,369 | $10.32M | Insider |
| Lutz Finger | 11.70% | 1,205,540 | $2.56M | Insider |
| Eli David | 6.65% | 685,482 | $1.46M | Insider |
| Yaron Eitan | 5.84% | 601,454 | $1.28M | Insider |
| Edmundo Gonzalez | 3.32% | 342,325 | $727.44k | Insider |
| John Paul Powers | 1.46% | 150,000 | $318.75k | Insider |
| Michael Charles Dendy | 1.40% | 143,850 | $305.68k | Insider |
| Vanguard Group Inc | 0.94% | 96,992 | $206.11k | Institution |
| Robert M. Pons | 0.72% | 74,200 | $157.68k | Insider |
| Cubist Systematic Strategies LLC | 0.72% | 74,039 | $157.33k | Institution |
MRAI vs Healthcare Plan Stocks
Marpai Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.